FDA Takes Important Step to Expand Access to Medication Abortion Care
Statement from Lourdes Rivera, Senior Vice President of U.S. Programs at the Center for Reproductive Rights: “Today, the U.S. Food and Drug Administration (FDA) announced they are permanently lifting some of the medically unnecessary and harmful restrictions on mifepristone, a medication used for early abortion and miscarriage care. We applaud the FDA for removing the […]